Total submissions: 19
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004562271 | SCV000166057 | benign | Familial adenomatous polyposis 1 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000131590 | SCV000186602 | benign | Hereditary cancer-predisposing syndrome | 2015-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000587624 | SCV000209549 | likely benign | not provided | 2020-08-25 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24728327, 25801821, 23910461, 11818965, 28389531) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587624 | SCV000694118 | benign | not provided | 2016-03-25 | criteria provided, single submitter | clinical testing | Variant Summary: The c.7490C>T variant involves the alteration of a conserved nucleotide and 3/4 in silico tools predict a neutral outcome. The variant was observed in the large and broad cohorts of the ExAC project at an allele frequency of 0.033%, predominantly observed in the European (Non-Finnish) subpopulation at a frequency of 0.055%. This frequency exceeds the maximal expected allele frequency for a pathogenic variant in APC (0.006%), suggesting this is a benign polymorphism found primarily in population(s) of European origin. The variant was reported in a family affected by multiple colorectal adenomas and carcinoma, however was absent in two affected members and was present in 3 unaffected members, showing lack of segregation of the variant with disease (Al-Tassan_2002). While one reputable clinical lab has classified the variant as likely benign, others have classified it as a VUS. Considering the relatively high frequency of this variant in the general population as well as the lack of segregation seen in an affected family, this variant has been classified as Benign. |
Mendelics | RCV004562271 | SCV000838150 | benign | Familial adenomatous polyposis 1 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000131590 | SCV000910611 | benign | Hereditary cancer-predisposing syndrome | 2016-03-22 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000587624 | SCV001133368 | likely benign | not provided | 2020-02-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000587624 | SCV001154481 | uncertain significance | not provided | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001153055 | SCV001314303 | likely benign | APC-Associated Polyposis Disorders | 2019-02-19 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Institute for Clinical Genetics, |
RCV000587624 | SCV002011084 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000587624 | SCV002049735 | likely benign | not provided | 2021-04-06 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000120032 | SCV002069711 | likely benign | not specified | 2021-04-30 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000131590 | SCV002528093 | benign | Hereditary cancer-predisposing syndrome | 2020-06-10 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000120032 | SCV002550657 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004562271 | SCV005083665 | likely benign | Familial adenomatous polyposis 1 | 2024-04-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |
ITMI | RCV000120032 | SCV000084163 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Diagnostic Laboratory, |
RCV000587624 | SCV001744322 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000587624 | SCV001920215 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000587624 | SCV001952102 | likely benign | not provided | no assertion criteria provided | clinical testing |